Experiment 1094809
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV |
| Organism | Empty organism |
| Citation | LUEDKE,SL: LUEDKE,DW: PETRUSKA,P: BROUN,GO: REED,G: LEAVITT,J:. (1982). VINDESINE(VDS) MONOCHEMOTHERAPY FOR NON-SMALL CELL LUNG CANCER: A REPORT OF 45 CASES.. 66() |
| Amount utilized | |
| Compound isolated | |
| Disease | FIFTY-THREE PATIENTS WITH NON-SMALL CELL LUNG CANCER WERE TREATED WITH VINDESINE. OF THE 45 EVALUABLE PATIENTS, 11 (24%) HAD A PARTIAL RESPONSE. RESPONSES WERE ALL EVIDENT WITHIN 6 WEEKS. MEDIAN DURATION OF RESPONSE WAS 8 WEEKS FROM DOCUMENTATION. MEDIAN SURVIVAL WAS NOT IMPROVED AMONG RESPONDERS. THE MOST FREQUENT SIDE EFFECT WAS LEUKOPENIA. THE MOST TROUBLESOME TOXIC EFFECT WAS PERIPHERAL NEUROPATHY,WITH PATIENTS OLDER THAN 60 YEARS EXPERIENCING THIS MORE FREQUENTLY. ADMINISTRATION WAS BY IV BOLUS ONCE WEEKLY FOR 10 WEEKS,FOLLOWED BY 3 MG/SQ M BIWEEKLY. |
| Dose amount | 4.0 MG |
| Number | 1 |
| Qualitative result | EQUIVOCAL |
| Animal | HUMAN ADULT |
| Per unit | SQ M BODY SURFACE |
| Dose expression | DOSE |